Biotech

All Articles

Lundbeck indicators $2.5 B check for Longboard and its own epilepsy med

.After spying runaway success possibility in Longboard Pharmaceuticals' epilepsy med, human brain di...

Lilly decides on UK for 1st Gateway Laboratory in Europe

.Eli Lilly's Portal Labs is going worldwide, along with the U.K. government introducing today that t...

Jasper dials up dosage after hives feedbacks come and go promptly

.Jasper Rehab has actually mentioned full responses in 10 of the 12 persistent hives individuals who...

Transgene's viral cancer cells injection flunks midphase test

.Transgene's therapeutic vaccination prospect TG4001 has actually failed a stage 2 solid lump trial....

Upstream swells IPO to $255M as it provides together with CAMP4

.Upstream Biography has puffy its own IPO to $255 thousand as the provider participates in CAMP4 Reh...

Sanofi flunks MS research, dealing one more strike to Denali deal

.Sanofi has ceased a phase 2 hardship of Denali Therapeutics-partnered oditrasertib in numerous scle...

Turnstone gives up 60%, agitates C-suite to stretch out cash

.Turnstone Biologics is actually decreasing its head count through 60% as well as shaking up its own...

Gilead gives up on $15M MASH bet after mulling preclinical records

.In a year that has viewed a confirmation and a raft of readouts for metabolic dysfunction-associate...

Texas biotech centers cancer treaty, pins wishes on weight problems

.Alaunos Therapeutics is actually axing a deal with Precigen, giving up licensing liberties to a tai...

Capricor portions even more information for DMD therapy after launching BLA

.Capricor Rehabs is taking a triumph tour for their phase 2 Duchenne muscle dystrophy (DMD) trial. A...